Ignite Creation Date:
2025-12-24 @ 4:46 PM
Ignite Modification Date:
2026-04-02 @ 7:09 AM
Study NCT ID:
NCT01004250
Status:
COMPLETED
Last Update Posted:
2014-05-21
First Post:
2009-10-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Pemetrexed and Bevacizumab for Participants With Advanced Non-Small Cell Cancer
Sponsor:
Eli Lilly and Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
13034
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None